Publications by authors named "Laura Fregonese"

Claim this Profile
H
Hospital patient experiences of contact isolation for antimicrobial resistant organisms in relation to health care-associated infections: A systematic review and narrative synthesis of the evidence.
Laura Fregonese, Kay Currie, Lawrie Elliott

Am J Infect Control· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tuberculosis medicines for children in Europe: an unmet medical need.
Antonio Cherchi, Alexandra Vaz, Ana Coelho, Laura Fregonese, Steffen Thirstrup

ERJ Open Res· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current and future developments in the pharmacology of asthma and COPD: ERS seminar, Naples 2022.
Daiana Stolz, Maria Gabriella Matera, Paola Rogliani, Maarten van den Berge, Eleni Papakonstantinou, Laura Fregonese

Breathe (Sheff)· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nonclinical data supporting orphan medicinal product designations in the area of rare infectious diseases.
Maria E Sheean, Eva Malikova, Dinah Duarte, Giuseppe Capovilla, Laura Fregonese

Drug Discov Today· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Defining orphan conditions in the context of the European orphan regulation: challenges and evolution.
Daniel J O'Connor, Maria E Sheean, Matthias P Hofer, Stelios Tsigkos, Segundo Mariz, Laura Fregonese

Nat Rev Drug Discov· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A European regulatory perspective on cystic fibrosis: current treatments, trends in drug development and translational challenges for CFTR modulators.
Stefano Ponzano, Giulia Nigrelli, Laura Fregonese, Irmgard Eichler, Fabio Bertozzi

Eur Respir Rev· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Establishing rarity in the context of orphan medicinal product designation in the European Union.
Stelios Tsigkos, Matthias Philipp Hofer, Maria Elzbieta Sheean, Segundo Mariz, Kristina Larsson, Laura Fregonese

Drug Discov Today· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Challenges and opportunities in the vertical transmission of Chagas disease].
María Isabel González-Tomé, Milagros García López-Hortelano, Laura Fregonese

An Pediatr (Engl Ed)· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Demonstrating significant benefit of orphan medicines: analysis of 15 years of experience in Europe.
Laura Fregonese, Lesley Greene, Matthias Hofer, Armando Magrelli, Frauke Naumann-Winter

Drug Discov Today· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
European Respiratory Society International Congress 2017: highlights from the Clinical Assembly.
Nicolas Kahn, Evgeni Mekov, Laura Fregonese, Vasileios Andrianopoulos, Frits M E Franssen

ERJ Open Res· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical highlights from the 2016 European Respiratory Society International Congress.
Nicolas Kahn, Laura Fregonese, Miriam Barrecheguren, Frits M E Franssen, Aleksandar Grgic

ERJ Open Res· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum to: Establishing medical plausibility in the context of orphan medicines designation in the European Union.
Stelios Tsigkos, Segundo Mariz, Jordi Llinares, Laura Fregonese, Stiina Aarum

Orphanet J Rare Dis· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The future of the development of medicines in idiopathic pulmonary fibrosis.
Laura Fregonese, Irmgard Eichler

BMC Med· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Steps forward in regulatory pathways for acute and chronic heart failure.
Luca Pani, Sergio Pecorelli, Giuseppe Rosano, Stefan D Anker, Andrea Peracino, Laura Fregonese

Eur J Heart Fail· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Steps forward in regulatory pathways for acute and chronic heart failure.
Luca Pani, Sergio Pecorelli, Giuseppe Rosano, Stefan D Anker, Andrea Peracino, Laura Fregonese

ESC Heart Fail· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Establishing medical plausibility in the context of orphan medicines designation in the European Union.
Stelios Tsigkos, Segundo Mariz, Jordi Llinares, Laura Fregonese, Stiina Aarum

Orphanet J Rare Dis· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A conceptual framework for reporting experience of physical activity in COPD.
Enrico M Clini, Laura Fregonese

Eur Respir J· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of biomarkers in the context of orphan medicines designation in the European Union.
Stelios Tsigkos, Jordi Llinares, Segundo Mariz, Stiina Aarum, Laura Fregonese

Orphanet J Rare Dis· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Profiling the proteome of exhaled breath condensate in healthy smokers and COPD patients by LC-MS/MS.
Marco Fumagalli, Fabio Ferrari, Maurizio Luisetti, Jan Stolk, Pieter S Hiemstra, Laura Fregonese

Int J Mol Sci· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term variability of desmosine/isodesmosine as biomarker in alpha-1-antritrypsin deficiency-related COPD.
Laura Fregonese, Fabio Ferrari, Marco Fumagalli, Maurizio Luisetti, Jan Stolk

COPD· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A syringe simulation of biological controls for quality assessment of prospective lung volume measurements.
Maarten K Ninaber, Robert Schot, Laura Fregonese, Jan Stolk

Respiration· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proteomic analysis of exhaled breath condensate from single patients with pulmonary emphysema associated to alpha1-antitrypsin deficiency.
Marco Fumagalli, Lorenzo Dolcini, Alberto Sala, Jan Stolk, Laura Fregonese

J Proteomics· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alpha-1 antitrypsin Null mutations and severity of emphysema.
Laura Fregonese, Jan Stolk, Rune R Frants, Barbera Veldhuisen

Respir Med· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hereditary alpha-1-antitrypsin deficiency and its clinical consequences.
Laura Fregonese, Jan Stolk

Orphanet J Rare Dis· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of the anaphylatoxin receptors C3aR and C5aR is increased in fatal asthma.
Laura Fregonese, Fiona J Swan, Annemarie van Schadewijk, Marisa Dolhnikoff, Mario A Santos

J Allergy Clin Immunol· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis